rethinkPeptides Search
Menu
Study breakdown

Human Beta-Defensin 3: A Bridge Between Innate Immunity and Adaptive Immune Activation

evidence
The takeaway

HBD-3 functions as a transcriptional convergence point linking innate antimicrobial defense to adaptive immune activation through regulation of both direct bacterial killing and immune cell signaling pathways.

Immune bridge molecule

HBD-3 simultaneously kills bacteria (innate immunity) and activates dendritic cells and T cells (adaptive immunity) — a rare dual-function immune molecule

What the researchers found

HBD-3 serves as a transcriptional convergence point: directly kills pathogens (innate), activates dendritic cells, modulates T cells, and regulates inflammatory gene expression (adaptive), bridging both immune branches.

Why it matters

Understanding that HBD-3 coordinates both immune branches could enable peptide-based immunotherapies that activate comprehensive immune responses.

How the study worked

Review of HBD-3 antimicrobial mechanisms, immune cell activation studies, transcriptional regulation, and its role as an innate-adaptive immunity bridge.

What this study cannot tell us

Review. Many mechanistic insights from in vitro studies. Clinical exploitation of HBD-3's dual role is theoretical.

How to read the evidence

Review of mechanistic and immunological studies. Well-established individual functions; bridge concept is an emerging synthesis.

When this study was published

Published in 2025.

The bigger picture

HBD-3 exemplifies how antimicrobial peptides are not just primitive killers but sophisticated immune orchestrators with therapeutic potential far beyond direct antimicrobial activity.

Questions still open

  • Could HBD-3 be used as a vaccine adjuvant to boost both innate and adaptive immunity?
  • Is the immune-bridging function unique to HBD-3 or shared by other defensins?
  • Would recombinant HBD-3 maintain its dual functionality?

Common questions

What makes HBD-3 special among antimicrobial peptides?
Most AMPs simply kill bacteria. HBD-3 also activates the adaptive immune system — training immune cells to mount targeted, lasting responses. It bridges the gap between fast-acting and long-lasting immunity.
Could HBD-3 improve vaccines?
Potentially. Its ability to activate both innate killing and adaptive immune learning makes it an ideal candidate for vaccine adjuvants that enhance both immediate and long-term immune responses.

Read the original research

Human β-defensin-3 as a transcriptional convergence point linking innate immunity, endocrine signals, and tissue repair.

Peptides, 171476

Citation

Jacobo-Delgado, Yolanda M; Huerta-Elías, Jaime Eduardo; Cabral-Venegas, Valeria; García-Hernández, Mariana; Rivas-Santiago, Bruno. (2026). Human β-defensin-3 as a transcriptional convergence point linking innate immunity, endocrine signals, and tissue repair.. Peptides, 171476. https://doi.org/10.1016/j.peptides.2026.171476